Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Casado JL, Quereda C, Moreno A, Pérez-Elías MJ, Martí-Belda P, Moreno S.

    Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection

    JOURNAL OF VIRAL HEPATITIS . 20(12): 829-837. Nº de citas: 27

    [doi:10.1111/jvh.12108]

  • Vallejo C, Vázquez L, Cabrera Martín JR, Carreras E, García Rodríguez J, Ruiz Camps I, Fortún J, Mensa J, Barberán J.

    Treatment of invasive fungal infections in high-risk haematological patients: What have we learnt in the past 10 years?

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 26(4): 378-386. Nº de citas: 11

  • Lodi S, Fisher M, Phillips A, De Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, Guiguet M, Porter K.

    Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection

    Plos One . 8(11): . Nº de citas: 14

    [doi:10.1371/journal.pone.0078642]

  • Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G, SINGLE Investigators.

    Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.

    NEW ENGLAND JOURNAL OF MEDICINE . 369(19): 1807-1818. Nº de citas: 733

    [doi:10.1056/NEJMoa1215541]

  • Monge-Maillo B, López-Vélez R.

    Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis

    Drugs . 73(17): 1889-1920. Nº de citas: 54

    [doi:10.1007/s40265-013-0132-1]

  • Torres M, González C, del Romero J, Viciana P, Ocampo A, Rodríguez-Fortúnez P, Masiá M, Blanco JR, Portilla J, Rodríguez C, Hernández-Novoa B, del Amo J, Ortiz M.

    Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort

    JOURNAL OF CLINICAL MICROBIOLOGY . 51(11): 3512-3520. Nº de citas: 41

    [doi:10.1128/JCM.01405-13]

  • Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Molina J, Lopez-Medrano F, Ruiz E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MA, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.

    Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy

    CLINICAL MICROBIOLOGY AND INFECTION . 19(11): 1049-1057. Nº de citas: 65

    [doi:10.1111/1469-0691.12108]

  • Monge-Maillo B, López-Vélez R.

    Therapeutic Options for Visceral Leishmaniasis

    Drugs . 73(17): 1863-1888. Nº de citas: 125

    [doi:10.1007/s40265-013-0133-0]

  • Ruiz-Garbajosa P, Curiao T, Tato M, Gijón D, Pintado V, Valverde A, Baquero F, Morosini MI, Coque TM, Cantón R.

    Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(11): 2487-2492. Nº de citas: 46

    [doi:10.1093/jac/dkt237]

  • Norman FF, López-Vélez R.

    Chagas Disease and Breast-feeding

    EMERGING INFECTIOUS DISEASES . 19(10): 1561-1566. Nº de citas: 40

    [doi:10.3201/eid1910.130203]

  • Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R.

    Melioidosis in Traveler from Africa to Spain

    EMERGING INFECTIOUS DISEASES . 19(10): 1656-1659. Nº de citas: 22

    [doi:10.3201/eid1910.121785]

  • Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J.

    Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance

    CLINICAL MICROBIOLOGY AND INFECTION . 19(10): 962-968. Nº de citas: 103

    [doi:10.1111/1469-0691.12089]

  • Cervero M, Agud JL, Torres R, García-Lacalle C, Alcázar V, Jusdado JJ, Moreno S.

    Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy

    HIV MEDICINE . 14(9): 556-562. Nº de citas: 18

    [doi:10.1111/hiv.12049]

  • Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S.

    Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1-Infected Individuals

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 149-153. Nº de citas: 48

    [doi:10.1097/QAI.0b013e31829a2f12]

  • Anta L, Blanco JL, Llibre JM, García F, Pérez-Elías MJ, Aguilera A, Pérez-Romero P, Caballero E, Vidal C, Cañizares A, Gutiérrez F, Dalmau D, Iribarren JA, Soriano V, de Mendoza C.

    Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(9): 1994-2002. Nº de citas: 10

    [doi:10.1093/jac/dkt146]

  • González C, Torres M, Benito A, Del Romero J, Rodríguez C, Fontillón M, Trastoy M, Viciana P, Del Amo J, Ortiz M, Hernández-Novoa B.

    Anal squamous intraepithelial lesions are frequent among young HIV-infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS-HPV)

    INTERNATIONAL JOURNAL OF CANCER . 133(5): 1164-1172. Nº de citas: 23

    [doi:10.1002/ijc.28102]

  • Cisneros JM, Cobo J, San Juan R, Montejo M, Fariñas MC.

    Education on antibiotic use. Education systems and activities that work.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31 Suppl 4: 31-37.

    [doi:10.1016/S0213-005X(13)70130-7]

  • Castronuovo D, Cacopardo B, Pinzone MR, Di Rosa M, Martellotta F, Schioppa O, Moreno S, Nunnari G.

    Bone disease in the setting of HIV infection: update and review of the literature

    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES . 17(18): 2413-2419. Nº de citas: 36